SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹860 Cr | ₹4,735 Cr | ₹-608 Cr | ₹-1,934 Cr | ₹726 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹860 Cr |
Mar2024 | ₹4,735 Cr |
Mar2023 | ₹-608 Cr |
Mar2022 | ₹-1,934 Cr |
Mar2021 | ₹726 Cr |
How is Net Cash Inflow / Outflow of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹860 Cr | -81.83 | |
Mar2024 | ₹4,735 Cr | Positive | |
Mar2023 | ₹-608 Cr | Negative | |
Mar2022 | ₹-1,934 Cr | Negative | |
Mar2021 | ₹726 Cr | - |
Compare Net Cash Inflow / Outflow of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹380,660.9 Cr | -3.5% | 0% | -12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,060.0 Cr | -6.6% | -7.2% | 9.8% | Stock Analytics | |
CIPLA | ₹121,080.0 Cr | -2.8% | -5% | -7.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,605.0 Cr | -2.5% | -0.4% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,556.0 Cr | -3.8% | -0.6% | -4.2% | Stock Analytics | |
MANKIND PHARMA | ₹102,422.0 Cr | -4.4% | 0.3% | -7.7% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -3.5% |
0% |
-12.9% |
SENSEX | -2.7% |
-0.5% |
-5.3% |
You may also like the below Video Courses